Today: 26 March 2026
Subscribe
Browse Category

Stock Market 3 January 2026

Reddit stock jumps as Needham calls it the “new homepage” for AI answers

Reddit stock jumps as Needham calls it the “new homepage” for AI answers

Reddit shares jumped 5.3% to close at $241.89 Friday, near the session high, after a Needham analyst highlighted the platform’s growing role as a source for AI-generated answers. The move came as investors weighed bullish analyst notes and ongoing data-licensing deals with Google and OpenAI. The S&P 500 ETF rose 0.2%, while Meta fell 1.4% and Pinterest gained 2.7%. Reddit traded between $228.44 and $242.69.
3 January 2026
····
Rigetti (RGTI) stock jumps as quantum names rebound; SEC filing flags insider sale plan

Rigetti (RGTI) stock jumps as quantum names rebound; SEC filing flags insider sale plan

Rigetti shares jumped 6.6% to $23.60 Friday, trading over 37 million shares as tech stocks rebounded to start 2026. Director Alissa Fitzgerald filed to sell 59,316 shares, valued at about $1.31 million, after the close. The stock traded between $21.62 and $24.00. Investors are watching for U.S. jobs data Jan. 9 and Rigetti’s earnings in early March.
3 January 2026
··
Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom

Pfizer shares closed up 1.1% at $25.18 on Friday, after leading U.S. drugmakers in January list-price hikes, including a 15% increase for its COVID vaccine Comirnaty. The stock remains below its 52-week high of $27.69. Investors await Pfizer’s Feb. 3 earnings update and monitor upcoming U.S. jobs and inflation data.
3 January 2026
····
Starbucks stock today: SBUX slips after MrBeast tie-up as investors eye earnings and rates

Starbucks stock today: SBUX slips after MrBeast tie-up as investors eye earnings and rates

Starbucks shares closed down 0.3% at $83.97 Friday, about 29% below their 52-week high. The company announced a marketing tie-in with YouTube creator MrBeast’s “Beast Games” and a limited-time drink launching Jan. 14. Investors are watching upcoming earnings, U.S. store changes, and the timeline for Starbucks’ China joint venture with Boyu Capital.
3 January 2026
··
MercadoLibre stock (MELI) drops 2% as 2026 opens; traders eye $2,000 and next catalysts

MercadoLibre stock (MELI) drops 2% as 2026 opens; traders eye $2,000 and next catalysts

MercadoLibre shares fell 2.0% to $1,973.70 Friday, closing below both their 50-day and 200-day moving averages after Zacks Research downgraded the stock to “strong sell.” The stock now trades about 25% below its 52-week high, with a market cap near $100 billion. U.S. markets are closed Saturday. Investors await the company’s next earnings report, expected around Feb. 19.
3 January 2026
·
KLA stock surges nearly 5% to start 2026 as chip-gear rally puts KLAC near a new high

KLA stock surges nearly 5% to start 2026 as chip-gear rally puts KLAC near a new high

KLA shares closed up 4.89% at $1,274.47 Friday, near their 52-week high, as semiconductor equipment stocks rallied on the first trading day of 2026. The Philadelphia Semiconductor Index rose 4%, with Lam Research and Applied Materials also posting strong gains. ASML’s U.S. shares jumped 8.8% after an analyst upgrade. Investors now await U.S. jobs data and KLA’s upcoming earnings report.
3 January 2026
·
Merck stock starts 2026 higher as Cidara tender-offer deadline hits next week

Merck stock starts 2026 higher as Cidara tender-offer deadline hits next week

Merck shares rose 1.2% to $106.45 Friday after Nasdaq set Jan. 6 as the expiration for its $9.2 billion cash tender offer for Cidara Therapeutics. Cidara shares will be halted after Jan. 6 and suspended Jan. 8 if the merger closes as planned. Merck’s move snapped a three-day losing streak, leaving the stock just below its 52-week high. About 10 million shares traded, below the 50-day average.
3 January 2026
···
1 … 665 666 667 668 669 … 1,363

Stock Market Today

  • Lovesac Q4 CY2025 Revenue Beats Estimates, Shares Rise Nearly 19%
    March 26, 2026, 8:30 AM EDT. Lovesac (NASDAQ:LOVE) reported Q4 CY2025 revenue of $248 million, up 2.7% year-on-year and 2.5% above analyst estimates. GAAP earnings per share of $2.19 also surpassed forecasts by 7.2%. Despite this, the company issued muted guidance for Q1 CY2026, expecting $136 million in revenue, 5.5% below analyst projections. Operating margin declined to 18.1% from 19.7%, though free cash flow margin improved sharply to 31.6%. Over the past five years, Lovesac's compounded annual growth rate in sales was 16.8%, but growth has plateaued recently with flat revenue over two years. Analysts foresee modest 4.9% sales growth in the next 12 months, still lagging sector averages in the consumer discretionary space, which faces volatile demand and trend-driven product cycles.
Go toTop